Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Waters (WAT) to $352 from $374 and keeps an Outperform rating on the shares. The firm updated its model after valuing the new combined model of it and its acquisition of the Becton Dickinson Biosciences & Dx assets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT:
- Waters’ Transformative Merger with BD’s Biosciences: A Strategic Move for Long-term Growth
- Waters price target lowered to $330 from $375 at BofA
- DoorDash, Southwest downgraded: Wall Street’s top analyst calls
- Waters downgraded to Equal Weight from Overweight at Wells Fargo
- Cautious Hold Rating Amid Waters and Becton Dickinson Merger: Balancing Opportunities and Execution Risks